Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)‐associated coronavirus infection

YH Yang, YH Huang, YH Chuang… - Journal of medical …, 2005 - Wiley Online Library
The severe acute respiratory syndrome (SARS) is caused by infection with the SARS‐
associated coronavirus (SARS‐CoV) and characterized by severe pulmonary inflammation …

Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance

H Mo, G Zeng, X Ren, H Li, C Ke, Y Tan, C Cai… - …, 2006 - Wiley Online Library
Background: Severe acute respiratory syndrome (SARS) is a newly discovered disease
caused by a novel coronavirus. The present study studied the longitudinal profile of …

Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity

YS Lin, CF Lin, YT Fang, YM Kuo… - Clinical & …, 2005 - academic.oup.com
Both viral effect and immune-mediated mechanism are involved in the pathogenesis of
severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. In this …

Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection

W Chen, Z Xu, J Mu, L Yang, H Gan… - Journal of medical …, 2004 - microbiologyresearch.org
To understand the time-course of viraemia and antibody responses to severe acute
respiratory syndrome-associated coronavirus (SARS-CoV), RT-PCR and ELISA were used …

Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients

Y Shi, Z Wan, L Li, P Li, C Li, Q Ma, C Cao - Journal of clinical virology, 2004 - Elsevier
Background: SARS-Cov is the etiologic agent of severe acute respiratory syndrome. An
understanding of the antibody responses to the viral components is very important for …

Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients

Y Wang, Z Chang, J Ouyang, H Wei, R Yang… - DNA and cell …, 2005 - liebertpub.com
To evaluate humoral immunity against the SARS-associated coronavirus (SARS-CoV), we
studied the profiles of IgG antibodies to the nucleocapsid (N) and spike (S) proteins of SARS …

[HTML][HTML] Antibody responses to individual proteins of SARS coronavirus and their neutralization activities

M Qiu, Y Shi, Z Guo, Z Chen, R He, R Chen, D Zhou… - Microbes and …, 2005 - Elsevier
A novel coronavirus, the severe acute respiratory syndrome (SARS) coronavirus (SARS-
CoV), was identified as the causative agent of SARS. The profile of specific antibodies to …

Longitudinal analysis of severe acute respiratory syndrome (SARS) coronavirus-specific antibody in SARS patients

SC Chang, JT Wang, LM Huang, YC Chen… - Clinical and Vaccine …, 2005 - Am Soc Microbiol
The serum antibodies to severe acute respiratory syndrome (SARS) coronavirus of 18 SARS
patients were checked at 1 month and every 3 months after disease onset. All of them except …

Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies

K Ohnishi, M Sakaguchi, T Kaji, K Akagawa… - Japanese journal of …, 2005 - jstage.jst.go.jp
In order to establish immunological detection methods for severe acute respiratory
syndrome coronavirus (SARS-CoV), we established monoclonal antibodies directed against …

Molecular pathology in the lungs of severe acute respiratory syndrome patients

J Ye, B Zhang, J Xu, Q Chang, MA McNutt… - The American journal of …, 2007 - Elsevier
Severe acute respiratory syndrome (SARS) is a novel infectious disease with disastrous
clinical consequences, in which the lungs are the major target organs. Previous studies …